Package 69452-316-20

Brand: cevimeline

Generic: cevimeline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 69452-316-20
Digits Only 6945231620
Product NDC 69452-316
Product ID 69452-316_10e26216-a6d9-ab89-e063-6294a90a298c
Description

100 CAPSULE in 1 BOTTLE (69452-316-20)

Marketing

Marketing Status
Marketed Since 2024-01-17
Brand cevimeline
Generic cevimeline hydrochloride
Sample Package No

Linked Drug Pages (1)

CEVIMELINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "10e26216-a6d9-ab89-e063-6294a90a298c", "openfda": {"unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["0f15cb50-5917-c928-e063-6294a90ab284"], "manufacturer_name": ["Bionpharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69452-316-20)", "package_ndc": "69452-316-20", "marketing_start_date": "20240117"}], "brand_name": "CEVIMELINE", "product_id": "69452-316_10e26216-a6d9-ab89-e063-6294a90a298c", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "69452-316", "generic_name": "CEVIMELINE HYDROCHLORIDE", "labeler_name": "Bionpharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CEVIMELINE", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA218290", "marketing_category": "ANDA", "marketing_start_date": "20240117", "listing_expiration_date": "20261231"}